Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Iwonicz-Zdroj

4 clinical trials in Iwonicz-Zdroj, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Iwonicz-Zdroj at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Iwonicz-Zdroj

Open in trial search

Study of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Leo Pharma A/S

Psoriasis

Not recruiting

Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Dermatitis atopic

Not recruiting

Study on the Long-term Safety and Effectiveness of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.

Psoriasis

Not recruiting

Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Brodalumab
  • Sponsor:Leo Pharma A/S

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Iwonicz-Zdroj

What the registry says about research in the country

01 Dermatology Research

Ongoing clinical investigations focusing on chronic skin conditions, with particular emphasis on innovative treatments for moderate to severe cases.

  • Plaque Psoriasis Studies
  • Atopic Dermatitis Research
  • Long-term Safety Evaluations

Research aims to evaluate extended treatment efficacy and patient outcomes over a two-year period.

02 Inflammatory Conditions

Comprehensive studies examining autoimmune skin disorders and their management through targeted therapeutic approaches.

  • Novel Treatment Modalities
  • Patient Tolerance Assessment
  • Extended Safety Monitoring

Investigations focus on establishing long-term safety profiles and treatment effectiveness.

03 Therapeutic Innovations

Advanced research into specialized biologics and their application in treating chronic dermatological conditions.

  • BMS-986165 Clinical Evaluation
  • Lebrikizumab Studies
  • Quarterly Treatment Protocols

Studies aim to document adverse events and therapeutic responses in diverse patient populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.